Prnewswire

Published October 8, 2026

Psilera Greenlit to Initiate Phase 2 of NIH Grant for Alcohol Use Disorder - PR Newswire

Read the full story at Prnewswire

PRNewswire/ -- Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies,.